- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- July 2025
- 150 Pages
Global
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 150 Pages
United States
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 150 Pages
China
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 150 Pages
Germany
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 150 Pages
India
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 150 Pages
Canada
From €4403EUR$4,850USD£3,793GBP
- Report
- June 2026
- 50 Pages
Global
From €2406EUR$2,650USD£2,072GBP
- Report
- June 2026
- 50 Pages
Global
From €2406EUR$2,650USD£2,072GBP
- Report
- June 2026
- 50 Pages
Global
From €2406EUR$2,650USD£2,072GBP
Deoxycholic Acid is a bile acid used in Animal Pharmaceuticals as a treatment for bile acid malabsorption, a condition in which the body does not absorb enough bile acid from the intestine. It is also used to treat certain types of gallstones, as well as to reduce the risk of gallstone formation. Deoxycholic Acid is available in both oral and injectable forms, and is typically administered by veterinarians.
The Deoxycholic Acid market is driven by the increasing prevalence of bile acid malabsorption in animals, as well as the growing demand for animal pharmaceuticals. The market is also supported by the increasing awareness of animal health and the growing demand for animal pharmaceuticals.
Some companies in the Deoxycholic Acid market include Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, and Zoetis. Show Less Read more